Can Actikerall (fluorouracil 0.5% and salicylic acid 10%) be used to treat a wart in an immunocompetent adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Actikerall Be Used for Warts?

Actikerall (5-fluorouracil 0.5%/salicylic acid 10%) is not a first-line treatment for common warts in immunocompetent adults, but it can be considered as an alternative option, particularly for treatment-resistant cases. The British Association of Dermatologists guidelines do not specifically recommend this combination for standard wart treatment, though both components individually have established roles in wart management 1.

Evidence-Based Treatment Hierarchy

First-Line Recommendations (Strength A-B)

The 2014 BAD guidelines clearly establish the preferred treatments for hand warts 1:

  • Salicylic acid 15-26% applied daily after paring, with occlusion if possible, for 3-4 months (Strength A)
  • Cryotherapy with 15-30 second freeze cycles, repeated every 2-4 weeks for at least 3 months (Strength B)

Where Actikerall Fits

5-fluorouracil formulations receive only a Strength C recommendation for hand warts in the BAD guidelines, specifically noting "5% cream applied daily + occlusion for 4-12 weeks" 1. The Actikerall formulation (0.5% 5-FU/10% SA) is not explicitly mentioned in these guidelines.

Supporting Evidence for Off-Label Use

Despite the lack of guideline endorsement, research data suggests potential efficacy:

  • Meta-analysis data from 625 patients with common warts showed 63.4% complete healing with 5-FU/SA combination versus 23.1% with SA alone 2
  • For plantar warts specifically, response rates were 63.0% versus 11.0% 2
  • A case report demonstrated successful treatment of more than 50 treatment-resistant filiform facial warts using 5-FU 5%/SA 20% 3

Clinical Decision Algorithm

Use Actikerall for warts when:

  1. Standard treatments (SA 15-26% or cryotherapy) have failed after 3-4 months
  2. Patient has multiple treatment-resistant warts
  3. Cryotherapy is contraindicated or poorly tolerated
  4. Patient has darker skin where post-inflammatory changes from cryotherapy are concerning

Do NOT use as first-line because:

  • Lower strength of recommendation (C vs. A for standard SA)
  • Limited specific evidence for the 0.5% 5-FU formulation in warts
  • More established alternatives exist with stronger evidence

Important Caveats

The FDA labeling for Actikerall does not include warts as an approved indication - the drug labels provided 4 appear to be for "Acthar Gel" (a completely different medication), not Actikerall. This represents off-label use requiring informed consent.

For plantar warts specifically, the BAD guidelines list 5-FU as an "other treatment" option but emphasize that cure rates are lower at this site due to thicker cornified layers 1.

Avoid damaging surrounding skin during application, as this may spread the infection - a critical consideration mentioned repeatedly in the guidelines 1.

Practical Application

If using Actikerall off-label for warts:

  • Apply after thorough paring/debridement of the wart
  • Consider occlusion to enhance penetration
  • Treat for 4-12 weeks minimum
  • Protect surrounding normal skin during application
  • Monitor for local irritation (generally well-tolerated per research data 5)

Bottom line: Start with guideline-recommended salicylic acid 15-26% or cryotherapy first. Reserve Actikerall for treatment-resistant cases where you need the combined antiproliferative effect of 5-FU with the keratolytic action of salicylic acid 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.